Tiansheng Pharmaceutical Group Co Ltd Total Liabilities
Tiansheng Pharmaceutical Group Co Ltd total liabilities. Based on the latest financial reports, Tiansheng Pharmaceutical Group Co Ltd (002872) has total liabilities worth CN¥679.17 Million CNY (≈ $99.38 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Tiansheng Pharmaceutical Group Co Ltd (002872) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
Total liabilities of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. This chart illustrates how Tiansheng Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
Tiansheng Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tiansheng Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hydratec Industries NV
AS:HYDRA
|
Netherlands | €110.20 Million |
|
Fortune Ng Fung Food Hebei Co Ltd
SHG:600965
|
China | CN¥462.39 Million |
|
Qinhuangdao Port Co Ltd
F:QHD
|
Germany | €6.38 Billion |
|
Hudaco
JSE:HDC
|
South Africa | ZAC2.83 Billion |
|
Ribbon Communications Inc
NASDAQ:RBBN
|
USA | $750.25 Million |
|
Teraplast Bist
RO:TRP
|
Romania | RON904.86 Million |
|
First Community Corporation
NASDAQ:FCCO
|
USA | $1.91 Billion |
|
NI Holdings Inc
NASDAQ:NODK
|
USA | $300.01 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Tiansheng Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Tiansheng Pharmaceutical Group Co Ltd's balance sheet.
Liquidity & Leverage Metrics
Tiansheng Pharmaceutical Group Co Ltd Total Liabilities Ratios Explained
Tiansheng Pharmaceutical Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tiansheng Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
The table below shows the annual total liabilities of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥721.80 Million ≈ $105.62 Million |
+0.92% |
| 2023-12-31 | CN¥715.25 Million ≈ $104.66 Million |
-8.56% |
| 2022-12-31 | CN¥782.23 Million ≈ $114.47 Million |
-6.96% |
| 2021-12-31 | CN¥840.79 Million ≈ $123.03 Million |
-33.07% |
| 2020-12-31 | CN¥1.26 Billion ≈ $183.83 Million |
-12.59% |
| 2019-12-31 | CN¥1.44 Billion ≈ $210.31 Million |
-3.67% |
| 2018-12-31 | CN¥1.49 Billion ≈ $218.33 Million |
-15.09% |
| 2017-12-31 | CN¥1.76 Billion ≈ $257.13 Million |
+14.62% |
| 2016-12-31 | CN¥1.53 Billion ≈ $224.33 Million |
+23.91% |
| 2015-12-31 | CN¥1.24 Billion ≈ $181.04 Million |
+16.26% |
| 2014-12-31 | CN¥1.06 Billion ≈ $155.72 Million |
-1.58% |
| 2013-12-31 | CN¥1.08 Billion ≈ $158.21 Million |
+36.47% |
| 2012-12-31 | CN¥792.28 Million ≈ $115.94 Million |
-- |
About Tiansheng Pharmaceutical Group Co Ltd
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in… Read more